Novavax (NVAX) volatility elevated into Resolve trial failed its primary and secondary goals
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Up)Join SI Premium – FREE
Novavax (NVAX) September call option implied volatility is at 190, October is at 215, January is at 138; compared to its 52-week range of 61 to 201 into its Resolve trial failed its primary and secondary goals.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cadence Design Systems (CDNS) option implied volatility into quarter results
- Truist Financial Corp. (TFC) April weekly option implied volatility into quarter results
- HUYA Inc. (HUYA) May 5 calls active
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
